3Lapeyraque AL, Wagner E, Phan V, et al. Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations [J]. Pediatr Nephrol, 2008, 2,3 (8) : 1363.
3Bennish ML,Khan WA,Begum M,et al.Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh.Clin Infect Dis,2006,42:356-362.
4Gorge JN.How I treat patients with thrombotic thrombocytopenic purpura hemolytic uremic syndrome.Blood,2000,96:1223-1229.
5Shimazu T,Shimaoka M,Sugimoto H,et al.Does blood type B protect against haemolytic uraemic syndrome?An analysis of the 1996 Sakai outbreak of Esheichia Coil O157:H7(VTECO15.7)infection.JInfect,2000,41;45-49.
6Taylor CM, Chua C, Howie AJ, et al. Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome [J ]. Pediatr Nephrol,2004, 19(4):419-425.
7Zipfel PF, Skerka C. Complement dysfunction in hemolytic uremic syndrome[J]. Curr Opin Rheumatol, 2006,18(5):548-555.
8Dervenoulas J, Tsirigotis P, Bollas G, et al. Thrombotic thrombocytopenic purpura/Hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases[J]. Ann Hematol, 2000, 79(2):66-72.
9Oakes RS, Siegler RL, McReynolds MA, et al. Predictors of fatality in postdiarrheal hemolytic uremic syndrome [J ]. Pediatrics, 2006, 117(5):1656-1662.
10Garg AX, Salvadori M, Okell JM, et al. Albuminuria and estimated GFR 5 years after Escherichia Coli O157 hemolytic uremic syndrome: an updale [J], Am J Kidney Dis, 2008 , 51 (3) : 435-444.
